A retrospective cohort study assessing the chemotherapy effects after trifluridine/tipiracil (TFTD) and/or regorafenib treatment in Colorectal cancer patients
Latest Information Update: 03 Feb 2021
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 03 Feb 2021 New trial record
- 01 Feb 2021 Results published in the Anticancer Research